References
- Arriza J. L., Weinberger C., Cerelli G., Glaser T. M., Handelin B. L., Housman D. E., Evans R. M. Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 1987; 237: 268–275
- Funder J. W., Pearce P. T., Smith R., Smith A. I. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 1988; 242: 583–585
- Stewart P. M., Wallace A. M., Valentino R., Burt D., Shackleton C. H., Edwards C. R. Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age. Lancet 1987; 2: 821–824
- White P. C., Mune T., Agarwal A. K. 11β-hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess. Endocr Rev 1997; 18: 135–156
- Agarwal A. K., Monder C., Eckstein B., White P. C. Cloning and expression of rat cDNA encoding corticosteroid 11 beta-dehydrogenase. J Biol Chem 1989; 264: 18939–18943
- Tannin G. M., Agarwal A. K., Monder C., New M. I., White P. C. The human gene for 11 beta-hydroxysteroid dehydrogenase. Structure, tissue distribution, and chromosomal localization. J Biol Chem 1991; 266: 16653–16658
- Agarwal A. K., Tusie-Luna M. T., Monder C., White PC. Expression of 11 beta-hydroxysteroid dehydrogenase using recombinant vaccinia virus. Mol Endocrinol 1990; 4: 1827–1832
- Albiston A. L., Obeyesekere V. R., Smith R. E., Krozowski Z. S. Cloning and tissue distribution of the human 11-HSD type 2 enzyme. Mol Cell Endocrinol 1994; 105: R11–R17
- Agarwal A. K., Rogerson F. M., Mune T., White P. C. Gene structure and chromosomal localization of the human HSD11K gene encoding the kidney (type 2) isozyme of 11β-hydroxysteroid dehydrogenase. Genomics 1995; 29: 195–199
- Kyossev Z., Walker P. D., Reeves W. B. Immunolocalization of NAD-dependent 11β-hydroxysteroid dehydrogenase in human kidney and colon. Kidney Int 1996; 49: 271–281
- Ulick S., Levine L. S., Gunczler P., Zanconato G., Ramirez L. C., Rauh W., Rosler A., Bradlow H. L., New M. I. A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol. J Clin Endocrinol Metab 1979; 49: 757–764
- Mune T., Rogerson F. M., Nikkila H., Agarwal A. K., White P. C. Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenase. Nat Genet 1995; 10: 394–399
- Agarwal A. K., White P. C. Analysis of the promoter of the NAD+ dependent 11β-hydroxysteroid dehydrogenase (HSD11K) gene in JEG-3 human choriocarcinoma cells. Mol Cell Endocrinol 1996; 121: 93–99
- Stoos B. A., Naray-Fejes-Toth A., Carretero O. A., Ito S., Fejes-Toth G. Characterization of a mouse cortical collecting duct cell line. Kidney Int 1991; 39: 1168–1175
- Prie D., Friedlander G., Coureau C., Vandewalle A., Cassingena R., Ronco P. M. Role of adenosine on glucagon-induced cAMP in human collecting duct cell line. Kidney Int 1995; 47: 1310–1318
- Dignam J. D., Martin P. L., Shastry B. S., Roeder R. G. Eukaryotic gene transcription with purified components. Methods Enzymol 1991; 101: 582–598